More than 80% of US adolescents received at least one dose of the meningococcal vaccine MenACWY. However, uptake of its first dose and completion of the booster dose varied by race or ethnicity, ...

The US Food and Drug Administration has approved a meningococcal vaccine against the five most common serogroups causing disease in children and young adults. The new formulation called Penbraya is ...

Any infection caused by the Neisseria meningitidis (N. meningitidis) bacteria is called meningococcal disease. Meningococcal disease is very serious. It can lead to limb amputations, hearing loss, ...

May 27 (Reuters) - French drugmaker Sanofi (SASY.PA), opens new tab said the U.S. Food and Drug Administration has approved its meningococcal vaccine for use in infants as young as six weeks, making ...